HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro and in vivo antitumor activity of doxorubicin-loaded alginic-acid-based nanoparticles.

Abstract
The antitumor activities of DOX-loaded alginic acid/poly[2-(diethylamino)ethyl methacrylate] (ALG-PDEA) nanoparticles are evaluated both in vitro and in vivo. TEM imaging shows that the ALG-PDEA NPs have a spherical morphology with a size of about 120 nm. CLSM observations reveal that the negatively charged ALG-PDEA NPs can be taken up well by cells. In vivo NIR fluorescence imaging shows that the ALG-PDEA NPs can passively target the tumor area because of the EPR effect in the H22 tumor-bearing mouse. In vivo antitumor efficacy examinations indicate that DOX-loaded ALG-PDEA NPs have significantly superior efficacy in impeding tumor growth compared to free DOX and low toxicity to living mice.
AuthorsYuan Cheng, Shuling Yu, Jingjing Wang, Hanqing Qian, Wei Wu, Xiqun Jiang
JournalMacromolecular bioscience (Macromol Biosci) Vol. 12 Issue 10 Pg. 1326-35 (Oct 2012) ISSN: 1616-5195 [Electronic] Germany
PMID22887841 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Alginates
  • Antibiotics, Antineoplastic
  • Drug Carriers
  • Fluorescent Dyes
  • Polymethacrylic Acids
  • alginic acid-poly(2-(diethylamino)ethyl methacrylate)
  • Doxorubicin
Topics
  • Alginates
  • Animals
  • Antibiotics, Antineoplastic (administration & dosage, pharmacokinetics, pharmacology)
  • Biological Transport
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Doxorubicin (administration & dosage, pharmacokinetics, pharmacology)
  • Drug Carriers
  • Drug Compounding
  • Fluorescent Dyes
  • Liver Neoplasms (drug therapy, pathology)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Microscopy, Electron, Transmission
  • Microscopy, Fluorescence
  • Nanoparticles
  • Neoplasm Transplantation
  • Optical Imaging
  • Particle Size
  • Polymethacrylic Acids

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: